2Elit L,Hirte H.Novel strategies for systemic treatment of endometrial cancer[J].Exp Opin Invest Druds,2000,9(12):2831-2853.
3Mundt AJ,Connell PP.Do conventional pathologic features lose their prognostic significance following postoperative radiation therapy in pathologic stage endometrial adenocar cinoma[J].Int J Cancer (Radiat Oncol Invest),2000,90:224.
5Ben-shachar I,Pavelka J,Cohn DE et al.surgical staging for patients presenting with grade I endometrial Carcinoma[J].Obstet Gynecol,2005,105(3):487-493.
2Morrow CP,Bundy BN,Kurman RJ,et al.Relationship between surgical-pathological risk factors and outcome in clinical stage Ⅰ andⅡ carcinoma of the enodmetrium:a Gynecologic Oncology Group study[J].Gyncecol Oncol,1991,40:55-65.
3Kilgore LC,Partridege EE,Alvarez RD,et al.Adenocarcinoma of the endometrium:survival comparisons of patients with and without pelvic node sampling[J].Gynecol concol,1995,56:29-33.
4Lin HH,Chen CD,Chen CK,et al.Is total abdominal hysterectomy with bilateral salpingo-oophorectomy adequate for new FIGO stage Ⅰ endometrial carcinoma[J].Br J Obstet Gynecol,1995,102:148-152.
5Kim YB,Niloff JM.Endometrial carcinoma:analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy[J].Obstet Gynecol,1993,82:175-180.
6Creutzberg CL,van Putten WL,Koper PC,et al.Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1endometrial carcinoma:multicentre randomised trial.PORTEC Study Group.Post Operative Radiation Therapy in Endometrial Carcinoma[J].Lancet,2000,355(9213):1404-1411.
7Creutzberg CL,van Putten WL,Koper PC,et al.Survival after relapse in patients with endometrial cancer:results from a randomized trial[J].Gynecol Oncol,2003,89:201-209.
8Scholten AN,van Putten WL,Beerman H,et al.Postoperative radiotherapy for stage 1 endometrial carcinoma:long-term outcome of the randomized PORTEC trial with central pathology review[J].Int J Radiat Oncol Biol Phys,2005,63(3):834-838.
9Keys HM,Roberts JA,Brunetto VL,et al.A phase Ⅲ trial of surgery with or without adjuvant external pelvic radiation therapy in intermediate risk endometrial adenomcarcinoma:a GOG study [ J].Gynecol Oncol,2004,92:744-751.
10Creutzberg CL,van Putten WL,Koper PC,et al.The morbidity of treatment for patients with stage 1 endometrial cancer:results from a randomized trial[J].Int J Radiat Oncol Biol Phys,2001,51 (5):1246-1255.
3Levine RJ,Maynard SE,Qian C,et al.Circulating angiogenic factors and the risk of preeclampsia[J].N Engl J Med,2004(7):672-683.
4Bradley WH,Boente MP,Brooker D,et al.Hysteroscopy and cytology in endometrial cancer[J].Obstet Gynecol,2004(5):1030-1033.
5连利娟.林巧稚妇科肿癌系[M].4版.北京:人民卫生出版社,2006:452-478.
6[2]Cust AE,Kaaks R,Friedenreich C,et al.Metabolic syndrome,plasma lipid,lipoprotein and glucose levels,and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition(EPIC)[J].Endocr Relat Cancer,2007,14(3):755-767.
7[5]Yazigi R,Cohen J,Munoz AK,et al.Magetic resonance imaging determination of myometrial invasion in endometrial carcinoma[J].Gynecol Oncol,1989,34(1):94-97.
8[6]Kurihawa T,Mieunuma H,Obsra M,et al.Determination of.normal level of serum CA125 in postmenopausal women as a toll for preoperative evaluation and postoperative surveillance of endometrial carcinoma[J].Gynecol oncol,1998,69(3):192.
9[8]Lubusky M,Dzvincuk P,Pilka R,et al.Preoperative assessment of myometrial invasion in endometrial cancer patients by ultrasonography and magnetic resonance imaging(MRI)[J].Ceska Gynekol,2006,71(5):394-398.
10[9]Scoutt LM,Mc Carthy SM,Flynn SD,et al.Clinical stage I endometrial carcinoma:pitfalls in preoperative assessment with MR imaging Work in progress[J].Radiology,1995,194(2):567-572.
